Drugs / Mature dendritic cell (DC) vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03092453 | May 2017 → Mar 2023 | melanoma | University of Pennsylvania | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mature dendritic cell (DC) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03092453 ↗ |
| Modality | Vaccine | “dendritic cells (a kind of white blood cell) as a vaccine” NCT03092453 ↗ |